Seyyed Mohmmad Reza Parizadeh
Department of Nutrition and Biochemistry and Cardiovascular Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran,
Reza Shafiee-Nick
Department of Pharmacology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
Maryam Sabery-Karimian
Department of Nutrition and Biochemistry and Cardiovascular Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran,
Majid Ghayour-Mobarhan
Department of Nutrition and Biochemistry and Cardiovascular Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran,
Gordon A.A. Ferns
Institute for Science and Technology in Medicine, University of Keele, Guy Hilton Research Centre, Thornburrow Drive, Stoke on Trent, Staffordshire, ST4 7QB, UK
ABSTRACT
We have investigated the metabolic effects of IBMX (3-isobutyl-1-methyl xanthine, a non-selective PDE inhibitor), amrinone, MC7 (6-(4-(tetrahydro-2H-pyran-4-yl)-4-oxobutoxy)-4-methylquinolin-2(1H)-one) and MC9 (6-(4-(1-ethylpiperidin-4-yl)-4-oxobutoxy)-4-methylquinolin-2(1H)-one) (selective PDE3 inhibitors) on immature balb/c mice. Controls included groups of mice that received no intervention (control 1) and a group injected with 1mg/kg of drug carrier (control 2). The four experimental groups were weighed and injected separately with IBMX, amrinone, MC7 and MC9 (1mg/kg) daily for seven days after which they were killed and 59 blood and tissue samples were collected. The administration of drug carrier into the male mice, decreased the growth pattern during the second (P<0.05) and third (P<0.001) day. After the injection of drug carrier, there wasnt any significant difference between the growth pattern, and the concentrations of biochemical factors in the male, comparing with female mice. Therefore, a group of mice, including both male and female, was used. MC7 decreased the growth pattern on the day two (P<0.01). IBMX increased glucose (P<0.05), triglyceride (P<0.05) and glycogen (P<0.01) concentrations, whereas amrinone decreased the glucose (P<0.05) comparing with control 2. The ability of stress tolerating in immature female mice was more than that in the male mice. In spite of the similar inhibition influence, the experimental drugs used in this study, had different metabolic effects.
PDF References
How to cite this article
Seyyed Mohmmad Reza Parizadeh, Reza Shafiee-Nick, Maryam Sabery-Karimian, Majid Ghayour-Mobarhan and Gordon A.A. Ferns, 2010. Investigating the Metabolic Effects of the Cyclic Nucleotide Phosphodiesterase Inhibitors on Immature balb/c Mice. Pakistan Journal of Nutrition, 9: 776-780.
DOI: 10.3923/pjn.2010.776.780
URL: https://scialert.net/abstract/?doi=pjn.2010.776.780
DOI: 10.3923/pjn.2010.776.780
URL: https://scialert.net/abstract/?doi=pjn.2010.776.780
REFERENCES
- Arner, P., J. Hellmer, E. Hagstrom-Toft and J. Bolinder, 1993. Effect of phosphodiesterase inhibition with amrinone or theophylline on lipolysis and blood flow in human adipose tissue in vivo as measured with microdialysis. J. Lipid Res., 34: 1737-1743.
Direct Link - Bender, A.T. and J.A. Beavo, 2006. Cyclic nucleotide phosphodiesterases: Molecular regulation to clinical use. Pharmacol. Rev., 58: 488-520.
CrossRef - Collins, S. and R.S. Surwit, 2001. The beta-adrenergic receptors and the control of adipose tissue metabolism and thermogenesis. Recent Prog. Horm Res., 56: 309-328.
PubMedDirect Link - Hagstrom-Toft, E., J. Bolinder, S. Eriksson and P. Arner, 1995. Role of phosphodiesterase III in the antilipolytic effect of insulin in vivo. Diabetes, 44: 1170-1175.
CrossRef - Ruttimann, Y., R. Chiolero, J.P. Revelly, N. Jeanpretre and Y. Schutz, 1994. Thermogenic effect of amrinone in healthy men. Crit. Care Med., 22: 1235-1240.
PubMed - Shakur, Y., L.S. Holst, T.R. Landstrom, M. Movsesian, E. Degerman and V. Manganiello, 2001. Regulation and function of the cyclic nucleotide phosphodiesterase (PDE3) gene family. Prog. Nucleic Acid Res. Mol. Biol., 66: 241-277.
PubMed - Snyder, P.B., 1999. The adipocyte cGMP-inhibited cyclic nucleotide phosphodiesterase (PDE3B) as a target for lipolytic and thermogenic agents for the treatment of obesity. Expert Opinion Therapeutic Targets, 4: 587-599.
CrossRefDirect Link - White, M.F. and C.R. Kahn, 1994. The insulin signaling system. J. Biol. Chem., 269: 1-4.
PubMedDirect Link - Wilmshurst, P.T., D.S. Thompson, S.M. Juul, B.S. Jenkins, D.J. Coltart and M.M. Webb-Peploe, 1984. Comparison of the effects of amrinone and sodium nitroprusside on haemodynamics, contractility and myocardial metabolism in patients with cardiac failure due to coronary artery disease and dilated cardiomyopathy. Br. Heart J., 52: 38-48.
PubMed - Zhao, A.Z., M.M. Shinohara, D. Huang, M. Shimizu and H. Eldar-Finkelman et al., 2000. Leptin induces insulin-like signaling that antagonizes cAMP elevation by glucagon in hepatocytes. J. Biol. Chem., 275: 11348-11354.
CrossRef - Zhao, A.Z., H. Zhao, J. Teague, W. Fujimoto and J.A. Beavo, 1997. Attenuation of insulin secretion by insulin-like growth factor 1 is mediated through activation of phosphodiesterase 3B. Proc. Natl. Acad. Sci. USA., 94: 3223-3228.
PubMed